This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback
Trial record 3 of 183 for:    "Tinnitus"

Tinnitus Related Cerebral Activities (ACCELA)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT02853812
First received: July 27, 2016
Last updated: August 3, 2016
Last verified: July 2016
  Purpose

The proposed research is to identify the brain areas activated or deactivated by tinnitus in humans. The identification of these areas is expected to be able to treat tinnitus refractory to traditional therapies by methods of brain stimulation. Furthermore, this technique would be very useful to verify the effectiveness of any treatment to relieve tinnitus.

The brain activation measured during fMRI will be performed in a position of rest, after inhibition of tinnitus, and after application of a sound that does not inhibit tinnitus. This comparison will identify specific brain areas activated or deactivated by tinnitus.


Condition Intervention
Tinnitus Other: Functional brain MRI

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Official Title: Tinnitus Related Cerebral Activities: Personalised Approach of the Tinnitus Treatment

Resource links provided by NLM:


Further study details as provided by University Hospital, Montpellier:

Primary Outcome Measures:
  • Measure of the BOLD activity by MRI [ Time Frame: 6 months ]
    Measure is done by MRI


Secondary Outcome Measures:
  • Measure of the BOLD activity on resting state by MRI [ Time Frame: 6 months ]
    Measure is done by MRI


Enrollment: 30
Study Start Date: March 2013
Estimated Study Completion Date: December 2016
Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
single sided tinnitus
patients with single sided tinnitus on which functional brain MRI is assessed
Other: Functional brain MRI
Sound evoked functional MRI assessment on patients with single sided tinnitus

Detailed Description:
  1. What is the purpose of the research?

    The proposed research is to identify the brain areas activated or deactivated by tinnitus in humans.

    The identification of these areas is expected to be able to treat tinnitus refractory to traditional therapies by methods of brain stimulation.

    Furthermore, this technique would be very useful to verify the effectiveness of any treatment to relieve tinnitus.

  2. What is the methodology?

    This is a diagnosis based on functional brain imaging with MRI (fMRI).

    The study will be conducted in 30 subjects with unilateral tinnitus, stable lesion of origin and can be inhibited by masking sound.

    The brain activation measured during fMRI will be performed in a position of rest, after inhibition of tinnitus, and after application of a sound that does not inhibit tinnitus.

    This comparison will identify specific brain areas activated or deactivated by tinnitus.

  3. What are the expected benefits?

Direct individual benefit could possibly be met by participants in this study. Indeed, the determination of a masking noise can afford to set up a masking system to reduce the tinnitus if the patient wishes.

Moreover, in case of identification of brain areas activated or inactivated by tinnitus in a subject, it may propose to carry out a transcranial magnetic brain stimulation of the area in an attempt to relieve the tinnitus, according to the stimulation protocols to date for tinnitus.

This will achieved a personalized approach to treating tinnitus.

Besides the expected individual benefit, other expected benefits are collective order, given the highly variable success rates, but generally limited treatments against tinnitus.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age limits to > 18 years and < 70 years
  • Voluntary study participation
  • Unhurt of any acute or chronic pathology of the ear (except tinnitus and a possible deafness of perception in the limits fixed below) on the basis of the interrogation and of the clinical examination
  • presenting a single sided tinnitus
  • Presenting on the side of the tinnitus a phenomenon of residual inhibition with a duration of total disappearance of the tinnitus of more than 30 seconds
  • easily reached
  • informed consent signed
  • Affiliation or recipient with the mode of social security

Exclusion Criteria:

  • Subjects incapable to understand the nature and the purposes of the study and/or having difficulty of communication with the investigator
  • majors protected by the law or privated of liberty by judiciary or administrative decision
  • pregnant woman
  • instable tinnitus (difference upper than 3 on mean of the EVA realised during the 5 days before the inclusion)
  • insufficient tinnitus intensity (mean of the EVA realised during the 5 days before the inclusion<4)
  • Anomaly of the external or average ear
  • Tinnitus attributed to a clearly identified retro-cochlear origin
  • Deafness of transmission of more than 15 dB on the tonal audiometry
  • Deafness of perception of more than 60 dB in average hearing loss (arithmetic mean) on the frequencies of 0,5-1-2 and 4 kHz.
  • Renowned ototoxic treatment during the duration of the protocol (malaria medicines, ototoxic chemotherapy, ototoxic antibiotic treatment),
  • Pursuit of a noise exposure of strong intensity with title professional and/or of leisure, dental treatment with use of engine or turbine, during the duration of the protocol.
  • Contraindication in the examination MRI (pacemaker, port of surgical clips in the cervico-cephalic region or implanted medical surgical material susceptible to mobilize under the influence of magnetic gradients, foreign body intraocular, pieces of shrapnel at the cervico-cephalic level (possibility of artefact), claustrophobia, pregnancy of less than 3 months)
  • History of cranial trauma with encephalic infringement(achievement), ischemic cerebrovascular accident or intracerebral bruise.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT02853812

Sponsors and Collaborators
University Hospital, Montpellier
Investigators
Study Chair: Frederic Venail, MD PhD CHU de Montpellier
  More Information

Responsible Party: University Hospital, Montpellier
ClinicalTrials.gov Identifier: NCT02853812     History of Changes
Other Study ID Numbers: 8847
Study First Received: July 27, 2016
Last Updated: August 3, 2016
Individual Participant Data  
Plan to Share IPD: No

Keywords provided by University Hospital, Montpellier:
tinnitus
residual inhibition

Additional relevant MeSH terms:
Tinnitus
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms

ClinicalTrials.gov processed this record on June 22, 2017